Cite
HARVARD Citation
Pratley, R. et al. (2022). Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline. BMJ open diabetes research and care. 10 (1), p. . [Online].